Intermediate risk NMIBC patients can be stratified in different groups based on their individual risk of progression to muscle-invasive disease. This risk-stratification tool may be useful to select the most appropriate therapy based on patients’ and tumor's characteristics.
Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies
Soria F.First
;Giordano A.;Gontero P.;
2021-01-01
Abstract
Intermediate risk NMIBC patients can be stratified in different groups based on their individual risk of progression to muscle-invasive disease. This risk-stratification tool may be useful to select the most appropriate therapy based on patients’ and tumor's characteristics.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2405456920301152-main.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
347.24 kB
Formato
Adobe PDF
|
347.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
